Pharming Group to report fourth quarter and full year 2024 financial results on March 13
Pharming Group N.V. confirms it will report its preliminary (unaudited) fourth quarter and full year 2024 financial results, for the period ended December 31, on Thursday, March 13, 2025.
Pharming will host a presentation for analysts and investors at 13:30 CET/08:30 am EDT on March 13, 2025.
To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.
Conference call registration:
Please note, the Company will only take questions from dial-in attendees.
https://register.vevent.com/register/BI7d716758d12d4ad588b70fdbca665b6a
To watch the live webcast, please register in advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/7qvoovac